Simavita releases progress update - Seite 3

North American update:

A new Canadian distributor, Medical Mart, was recently appointed to expand sales, marketing and our distribution network in Canada. Sales continue to grow in Canada with a new long-term care facility in Ontario signing a 1 year agreement.

In the United States, we have reviewed our exclusive distribution relationship with Medline with a view to redefining our relationships in this market. The parties are currently working together to finalise a revised distribution agreement. It is our clear intention to engage with active distributors in the region and to rapidly grow this major market.

A number of new relationships have commenced including:

• Christian Living, a long term care group in Colorado, with 3 Continuing Care Retirement Communities has signed a contract to use Simavita across the group. Continuing Care Retirement Communities include Skilling Nursing, Assisted Living and Independent Living facilities co-located on a single campus.
• A long term care group with 45 facilities has contracted to conduct a pilot at 2 of its Arizona facilities.

Australian update:

The Australian sales team has been refreshed. We're delighted to announce the appointment of Mr Brett Maybery as ANZ Sales Director. Brett has an enviable record in aged care sales and, in particular, has been successfully building significant sales in the field.

We have also set about building a strong sales team with a broad focus on aged care, community care including the National Disability Insurance Scheme (NDIS) as well as hospitals.

The new team has already built a strong pipeline that includes 4 new customers as well as sales of our new AssessPLUS product into existing customers. Furthermore we have determined 3 new and focused distributors for the region. In addition during the period, 4 new aged care facilities have agreed to implement SIM™.

We have decided to extend our network into New Zealand and have identified a strong and highly experienced partner to target the aged care and hospital markets.

With the imminent launch of AssessPLUS, the team have been focused on introducing new customers in the home care and disability care markets with highly encouraging early results. A recent trial with disability participants has shown very positive clinical results. Importantly, the trial pointed toward a strong reduction in real costs with a greater than 20% reduction in incontinence pads after implementing the SIM™ product capacity recommendations. A further 2 trials of disability participants are in the planning stages.